$21,690.74 research Payment -- Bristol-Myers Squibb to Dr. Benjamin Cook
Bristol-Myers Squibb disburses $21,690.74 for research to Hematologist Benjamin Cook
This page provides a detailed analysis of a $21,690.74 research payment from Bristol-Myers Squibb to Dr. Benjamin Cook. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $21,690.74 |
| Payment Type | research |
| Payment Nature | Research |
| Pharmaceutical Company | Bristol-Myers Squibb |
| Physician | Dr. Benjamin Cook |
| NPI Number | 1408247983 |
| Physician Specialty | Hematology |
| Location | Chicago, IL |
| Date of Payment | 2024-06-12 |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Bristol-Myers Squibb made a $21.7K research payment to Benjamin Cook, a Hematology specialist in Chicago, IL. The payment of $21,690.74 from Bristol-Myers Squibb to Dr. Benjamin Cook is categorized as 'research'. This payment was made on June 12, 2024, indicating a recent engagement. Dr. Cook, a Hematology specialist in Chicago, IL, received this payment, which is specifically for research purposes.
Patient Guidance: What This Payment Means for You
This payment was made to your physician for research activities. It is important to understand how such payments might influence medical advice. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Payments for research in Hematology can vary widely depending on the scope and phase of the study; this amount should be considered within the context of specific research agreements.
Regulatory Context: Sunshine Act Requirements
This payment is subject to reporting under the Physician Payments Sunshine Act, requiring disclosure of financial relationships between drug manufacturers and physicians.
Related Topics
This payment is related to the following healthcare transparency topics:
- cms-open-payments
- bristol-myers-squibb
- benjamin-cook
- hematology
- research-payment
- physician-payment
Understanding research Payments
Research payments fund clinical trials, research studies, and investigator-initiated research conducted by physicians. These payments are often the largest category and represent a critical part of the drug development process. Research funding is generally considered the most legitimate form of pharmaceutical payment, though potential conflicts of interest can still arise when researchers have financial relationships with the companies whose products they study.
Frequently Asked Questions About This Payment
What was this $21.7K payment for?
This was a research payment of $21.7K from Bristol-Myers Squibb to Benjamin Cook, categorized as "Research". The payment was reported under the Sunshine Act (CMS Open Payments).
Does Benjamin Cook accept pharmaceutical money?
Yes, Benjamin Cook received this $21.7K payment from Bristol-Myers Squibb. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Benjamin Cook's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this research payment?
A research payment of $21.7K typically funds clinical studies and is considered standard academic activity. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Hematology?
To compare this payment against Hematology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Hematology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Benjamin Cook's relationship with Bristol-Myers Squibb?
The payment amount is substantial, suggesting a significant research project or collaboration. This $21.7K research payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Hematology?
The 'research' payment type is distinct from payments for consulting, speaking, or meals.
What should patients do after learning about this payment?
This payment was made to your physician for research activities. It is important to understand how such payments might influence medical advice.
What else should I know about this research payment?
The payment was made directly to the physician, not an institution.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.